JanineV.KyrillosMDFACP
[Pronunciation: ker-rill-ose]
Internal Medicine • Bala Cynwyd, PAObesity Medicine & Nutrition
Medical Director, Jefferson Comprehensive Weight Management
Dr. Kyrillos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
225 E City Ave
Suite 10
Bala Cynwyd, PA 19004Phone+1 215-503-3838Fax+1 610-664-0827- Is this information wrong?
Summary
- Dr. Janine Kyrillos is an associate professor of medicine at Sidney Kimmel Medical College at Thomas Jefferson University In Philadelphia and is board certified in Internal Medicine and Obesity Medicine. She received her MD from Rutgers Robert Wood Johnson Medical School. She treats obesity, diabetes, metabolic syndrome using lifestyle changes, low carb diet, fasting, and medication management.
Education & Training
Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 2002- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHInternship, Internal Medicine, 1999 - 2000
Rutgers Robert Wood Johnson Medical SchoolClass of 1999
University of PennsylvaniaBSN, 1983 - 1987
Certifications & Licensure
NJ State Medical License 2021 - 2025
PA State Medical License 2000 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Obesity Medicine Obesity Medicine
Awards, Honors, & Recognition
- Top Doc Philadelphia Magazine, 2016-2023
- Top Doctor Castle Connolly, 2013-2019
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2011-2013
- Join now to see all
Publications & Presentations
PubMed
- 3 citationsSemaglutide 2.4-mg injection as a novel approach for chronic weight management.Janine Kyrillos> ;The American Journal of Managed Care. 2022 Dec 1
- Introducing an important therapy for obesity to primary care: once-weekly subcutaneous semaglutide 2.4 mg.Janine V Kyrillos, Patrick M O'Neil, Sean Wharton> ;Postgraduate Medicine. 2022 Jan 1
- Integrating semaglutide into obesity management - a primary care perspective.Janine V Kyrillos, Neil S Skolnik, Bhasha Mukhopadhyay, Nicholas Pennings> ;Postgraduate Medicine. 2022 Jan 1
Press Mentions
Doctors Labelling New Weight Loss Drug a ‘Game Changer'March 7th, 2021
Good Fats, Bad Fats, and Why the Ketogenic Diet MattersJuly 13th, 2018- Losing Weight After Menopause Is Tough. Here Are Tips That May HelpMay 19th, 2017
- Join now to see all
Professional Memberships
- Fellow
- American Board of Obesity MedicineDiplomate
- Obesity Medicine AssociationMember
Hospital Affiliations
Thomas Jefferson University HospitalPhiladelphia, Pennsylvania
Industry Relationships
- Member, Doximity Medical Advisory Board
- US Medical Education Obesity Advisory Board, Eli Lilly
- Speaker’s Bureau, Novo Nordisk Obesity Team
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
